Fenchem will formally launch a new product with patent support, named LevelLow, at the coming Vitafoods Europe. LevelLow is a new formula consisting of all-natural ingredients that targets hyperlipidemia and has received a grant from the USPTO with US Patent No.: 8,084,065, titled as “Compositions for treating and preventing hyperlipidemia." LevelLow will be demonstrated in the New Products Zone of Vitafoods Europe.
Nowadays hyperlipidemia is becoming a more and more serious issue and it plays a major role in the development of atherosclerosis, which is the main cause of blood vessel and heart diseases. LevelLow provides a composition capable of protecting against hyperlipidemia. Four natural ingredients-phytosterols, flavones derived from bamboo leaf, procyanidins and beta-glucan are combined in the formula. Based on abundant experience and large amounts of clinical experiments, the combination of the four kinds of compounds can achieve synergistic effect. Soluble fiber from foods such as beta-glucan, along with phytosterols, as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease.